
Bioorganic and Medicinal Chemistry Letters p. 1941 - 1946 (1996)
Update date:2022-08-05
Topics:
Mehrotra, Mukund M.
Sternbach, Daniel D.
Rodriguez, Marc
Charifson, Paul
Berman, Judd
The phosphopeptide 1 is a potent inhibitor of pp60(c-src) SH2 domain mediated phosphoprotein interactions (IC50 ≤ 0.5 μM), but lacks cell permeability. The syntheses of its less charged analogs 2 and 3 are described, in which the arginine-binding phosphate group has been substituted with uncharged α-dicarbonyl moieties. The chemistry described here may be of general use for the synthesis of other α-dicarbonyl compounds.
View MoreSuqian Ruixing Chemical Co., Ltd.
Contact:+86-527-80805666(总机);84836008(销售)
Address:3 Jingsilu, Zone north, Hubin Xincheng Development Park, Suqian, China
Shanghai better-in Medical Technology Co.,LTD.
Contact:+86-21-38921049
Address:Lane 720 zhangjianggaoke cailun road, Pudong, Shanghai, room 513
Contact:+86-29-88710656
Address:South Tai bai Road, High Tech Development Zone, Xi'an China
Hefei EnliPharma Tecnology Co.,Ltd
Contact:0086-551-66399836
Address:Qing Cheng ShuiXiang Building 805, Mengcheng North Road , ShuangFeng Economic Development Zone Anhui HeFei
Contact:732.938.2777
Address:5012 Industrial Road Farmingdale, NJ 07727
Doi:10.1016/S0040-4020(01)85085-7
(1994)Doi:10.1055/s-0031-1290067
(2012)Doi:10.1080/14756366.2019.1634704
(2019)Doi:10.1021/om101194f
(2011)Doi:10.1021/om5005594
(2014)Doi:10.1021/ja00170a045
(1990)